Examples of using Normal renal function in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
Patients with normal renal function.
No dose modifications are necessary in elderly patients with normal renal function.
In patients with normal renal function and no other complicating.
At least once a year in patients with normal renal function.
Patients with normal renal function should be monitored for changes in serum creatinine every 3 months
EDURANT has mainly been studied in patients with normal renal function.
For patients with normal renal function(defined as CLcr>
SIRTURO has mainly been studied in patients with normal renal function.
The degree of renal impairment was defined according to baseline creatinine clearance(CrCl) normal renal function when CrCl> 80 ml/ min;
No dosage adjustment necessary in patients with normal renal function.
The free drug clearance of imatinib is probably similar between patients with renal impairment and those with normal renal function, since renal excretion represents only a minor elimination pathway for imatinib see sections 4.2 and 4.4.
Liraglutide exposure was reduced in patients with renal impairment compared to individuals with normal renal function.
as compared to subjects with normal renal function.
The clearance of bivalirudin is similar in patients with normal renal function and those with mild renal impairment.
which decrease more slowly than in subjects with normal renal function.
Min infusion time should only be used for patients with normal renal function or mild renal impairment.
which decrease more slowly than in subjects with normal renal function.
The mean total AUC of febuxostat increased by approximately 1.8-fold from 7.5 μ g⋅ h/ ml in the normal renal function group to 13.2 μ g. h/ ml in the severe renal dysfunction group.
Zometa 4 mg/100 ml solution for infusion can be used immediately without further preparation for patients with normal renal function.
Most of the patients in the population pharmacokinetic analysis had normal renal function or mild renal impairment.
50 to 80 mL/min) and normal renal function.
The serum half-life of aztreonam averaged 1.7 hours in subjects with normal renal function, independent of the dose and route.
was administered immediately after haemodialysis, compared to that seen in subjects with normal renal function.
The contribution of renal excretion to total clearance in subjects with normal renal function was 65-85.
to 59 ml/min/1.73 m2) than in those with mild renal impairment or normal renal function.
In severe renal impairment, AUC was 30% higher than in subjects with normal renal function see section 4.2.
impairment(creatinine clearance 15-29 ml/minute) compared to subjects with normal renal function.
There were no clinically significant differences in the percent decrease in serum uric acid concentration in healthy subjects irrespective of their renal function 58% in the normal renal function group and 55% in the severe renal dysfunction group.
as compared to patients with normal renal function.